Is this innovation actually ready to be adopted?

Is the target clinical claim supported by evidence in the intended population and use setting?

Are outcomes clinically meaningful rather than only mechanistic or surrogate where not validated?

Are limitations, uncertainty, safety, and subgroup effects understood?

Can the evidence package withstand payer, clinician, regulator, and procurement review?

Does the product solve a clinically important problem with a clear place in care?

Is the intended user/patient population precisely defined?

Is the expected benefit large enough to change a real decision or outcome?

Is there a credible comparison against current care or alternatives?

Can the innovation fit into current clinical workflows without excessive burden?

Are roles, handoffs, alerts, escalation, and follow-up responsibilities clear?

Does it integrate with EHR/data systems or provide an acceptable alternative?

Can clinicians understand and act on outputs at the right moment?

Is there a viable reimbursement, budget, contracting, or value-based payment pathway?

Is the buyer's economic case quantified using the buyer's own relevant outcomes?

Are implementation, staffing, device, and integration costs included?

Does the model remain viable under plausible payment-policy changes?

Do clinicians and patients understand what the innovation does and does not do?

Are explainability, informed use, accessibility, and human factors adequate?

Are claims disciplined and aligned with evidence?

Is there a credible process for issues, corrections, and user feedback?

Is the regulatory status/pathway understood and appropriate to the intended use?

Are privacy, security, licensure, consent, and governance requirements addressed?

Are AI/device change-management and postmarket obligations addressed where relevant?

Are institutional approval and oversight pathways mapped?

Can the organization deploy, support, train, monitor, and scale the innovation?

Are integration, data exchange, identity, security, and support dependencies resolved?

Is there sufficient clinical/technical staffing and implementation ownership?

Can the solution operate reliably across sites and populations?

Are post-launch outcomes and safety/performance monitored?

Is there a feedback loop that changes product, protocol, or deployment when evidence changes?

Can results be compared across sites and populations?

Is there a credible path from pilot to repeatable institutional scale?